Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery: primary endpoint results, effect estimate with…
- Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas: Complete Statistical AnalysisIndependent statistical analysis of Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Nabilone in Cannabis Users With PTSD: Complete Statistical AnalysisIndependent statistical analysis of Nabilone in Cannabis Users With PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03251326).
- NABIS:HIIRIndependent statistical analysis of Effects of Hypothermia Upon Outcomes After Acute Traumatic Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00178711).
- NACIndependent statistical analysis of Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NACIndependent statistical analysis of N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02791945).
- NAC cold coughIndependent statistical analysis of Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- NAC MJ PilotIndependent statistical analysis of An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00542750).
- NAC Phase IIB: A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients: Complete Statistical AnalysisIndependent statistical analysis of NAC Phase IIB: A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients: primary endpoint…
- NAD+ Precursor Supplementation in Friedreich’s Ataxia: Complete Statistical AnalysisIndependent statistical analysis of NAD+ Precursor Supplementation in Friedreich's Ataxia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04817111).
- NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis: Complete Statistical AnalysisIndependent statistical analysis of NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis: primary endpoint results, effect estimate…
- NAFLDIndependent statistical analysis of Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NAFLDIndependent statistical analysis of Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NAFT-600Independent statistical analysis of Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NAITREIndependent statistical analysis of Neonates and Azithromycin, an Innovation in the Treatment of Children in Burkina Faso: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NALAIndependent statistical analysis of NALA, a randomized phase 3 trial of neratinib plus capecitabine versus lapatinib plus capecitabine in HER2+ metastatic breast cancer after two or more prior HER2-directed regimens.
- Naloxone, Hypoglycemia and Exercise: Complete Statistical AnalysisIndependent statistical analysis of Naloxone, Hypoglycemia and Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03149770).
- Nalrexone Facilitated Discontinuation of Buprenorphine: Complete Statistical AnalysisIndependent statistical analysis of Nalrexone Facilitated Discontinuation of Buprenorphine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01895036).
- Naltrexone & SSRI in Alcoholics With Depression/PTSD: Complete Statistical AnalysisIndependent statistical analysis of Naltrexone & SSRI in Alcoholics With Depression/PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00338962).
- Naltrexone for Impulse Control Disorders in Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Naltrexone for Impulse Control Disorders in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01052831).
- Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NAMESIndependent statistical analysis of Northwestern University and Access Community Health Network Medication Education Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01578577).
- NAPIndependent statistical analysis of Neural-net Artificial Pancreas (NAP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05876273).
- NAPEIndependent statistical analysis of Oatmeal Effect on N-acyl-phosphatidylethanolamines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03468179).
- Napping, Sleep, Cognitive Decline and Risk of Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03256539).
- Naproxen Sodium (2 x 220 mg) Fasted Comparative Bioavailability Study: Complete Statistical AnalysisIndependent statistical analysis of Naproxen Sodium (2 x 220 mg) Fasted Comparative Bioavailability Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03167541).
- NAPSIndependent statistical analysis of Nattokinase Atherothrombotic Prevention Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02080520).
- Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty: Complete Statistical AnalysisIndependent statistical analysis of Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03457116).
- NARLALIndependent statistical analysis of Navelbine And Radiotherapy in Locally Advanced Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00887783).
- Narrative Visualization for Breast Cancer Survivors’ Physical Activity: Complete Statistical AnalysisIndependent statistical analysis of Narrative Visualization for Breast Cancer Survivors' Physical Activity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03612596).
- Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.: Complete Statistical AnalysisIndependent statistical analysis of Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Nasal HFOV Versus Nasal CPAP to Reduce Post-extubation pCO2: Complete Statistical AnalysisIndependent statistical analysis of Nasal HFOV Versus Nasal CPAP to Reduce Post-extubation pCO2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02340299).
- Nasal Noninvasive NAVA in the Very Low Birth Weight Infant: Complete Statistical AnalysisIndependent statistical analysis of Nasal Noninvasive NAVA in the Very Low Birth Weight Infant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01785563).
- Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation: Complete Statistical AnalysisIndependent statistical analysis of Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00415493).
- Nasal Pillows vs. Nasal Masks at High CPAP Pressure: Complete Statistical AnalysisIndependent statistical analysis of Nasal Pillows vs. Nasal Masks at High CPAP Pressure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01690923).
- Nasal Tea Tree Oil for the Prevention of Infections in PD Patients: Complete Statistical AnalysisIndependent statistical analysis of Nasal Tea Tree Oil for the Prevention of Infections in PD Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nasal Versus Oral Midazolam Sedation in Routine Pediatric Dental Care: Complete Statistical AnalysisIndependent statistical analysis of Nasal Versus Oral Midazolam Sedation in Routine Pediatric Dental Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02679781).
- NASHIndependent statistical analysis of Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NASHIndependent statistical analysis of The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NASH Fitness Intervention in Thrombosis Trial (NASHFit): Complete Statistical AnalysisIndependent statistical analysis of NASH Fitness Intervention in Thrombosis Trial (NASHFit): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03518294).
- NASH-CXIndependent statistical analysis of Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis: primary endpoint results,…
- Nashville – Hypertension Management Model: Complete Statistical AnalysisIndependent statistical analysis of Nashville - Hypertension Management Model: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04232124).
- Nasotracheal Suction With Tiemann Catheter Compared to the Classic Technique With the Suction Catheter: Complete Statistical AnalysisIndependent statistical analysis of Nasotracheal Suction With Tiemann Catheter Compared to the Classic Technique With the Suction Catheter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NASQIndependent statistical analysis of Individualized Nutrition for Adult Recipients of Allogeneic Stem Cell Transplants - Effect on Quality of Life: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Natalizumab and Chronic Inflammation: Complete Statistical AnalysisIndependent statistical analysis of Natalizumab and Chronic Inflammation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05177718).
- Natalizumab High Titer Immunogenicity and Safety: Complete Statistical AnalysisIndependent statistical analysis of Natalizumab High Titer Immunogenicity and Safety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00516893).
- Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate: Complete Statistical AnalysisIndependent statistical analysis of Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC: Complete Statistical AnalysisIndependent statistical analysis of National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…